Mien-Chie Hung

Mien-Chie Hung (; born September 4, 1950) is a Taiwanese-American molecular biologist and cancer researcher. He was formerly a professor and chair of the Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center in Houston, Texas. He currently serves as the president of China Medical University in Taichung, Taiwan. Provided by Wikipedia
Showing 1 - 8 results of 8 for search 'Mien-Chie Hung', query time: 0.03s Refine Results
  1. 1
    Nuclear PKM2: a signal receiver, a gene programmer, and a metabolic modulator

    Nuclear PKM2: a signal receiver, a gene programmer, and a metabolic modulator by Tsan-Jan Chen, Chun-Hsien Wu, Mien-Chie Hung, Wen-Ching Wang, Hsing-Jien Kung

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    D-ribose-5-phosphate inactivates YAP and functions as a metabolic checkpoint

    D-ribose-5-phosphate inactivates YAP and functions as a metabolic checkpoint by Cheng-E Tu, Yong-Feng Liu, Hong-Wei Liu, Chun-Mei Jiao, Quentin Liu, Mien-Chie Hung, Peng Li, Xiang-Bo Wan, Xin-Juan Fan, Yun-Long Wang

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    WWOX tuning of oleic acid signaling orchestrates immunosuppressive macrophage polarization and sensitizes hepatocellular carcinoma to immunotherapy

    WWOX tuning of oleic acid signaling orchestrates immunosuppressive macrophage polarization and sensitizes hepatocellular carcinoma to immunotherapy by Min Xu, Mien-Chie Hung, Qiang Zhou, Wenxin Xu, Yong Yi, Yi Shi, Qiongzhu Dong, Ning Ren, Chenhao Zhou, Jialei Weng, Shaoqing Liu, Minghao Xu, Shiguang Yang, Zhiqiu Hu

    Published 2024-11-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Ribonuclease 1 Induces T‐Cell Dysfunction and Impairs CD8+ T‐Cell Cytotoxicity to Benefit Tumor Growth through Hijacking STAT1

    Ribonuclease 1 Induces T‐Cell Dysfunction and Impairs CD8+ T‐Cell Cytotoxicity to Benefit Tumor Growth through Hijacking STAT1 by Wen‐Hao Yang, Bao‐Yue Huang, Hsing‐Yu Rao, Peng Ye, Bi Chen, Hao‐Ching Wang, Chih‐Hung Chung, Heng‐Hsiung Wu, Hung‐Rong Yen, Shao‐Chun Wang, Jong‐Ho Cha, Xiuwen Yan, Muh‐Hwa Yang, Mien‐Chie Hung

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Anti-galectin-9 therapy synergizes with EGFR inhibition to reprogram the tumor microenvironment and overcome immune evasion

    Anti-galectin-9 therapy synergizes with EGFR inhibition to reprogram the tumor microenvironment and overcome immune evasion by Mien-Chie Hung, Jun Yao, Chia-Hung Chen, Chih-Yen Tu, Zhiguo Liu, Qihui Chen, Liyan Gu, Dongli Linghu, Jiaming Song, Chengjie Liu, Boning Liu, Riyao Yang, Swathi Priya Manickam, Navaneethan Sundhar, Delong Liu, Hsiao-Fan Chen, Shasha Shi, Shunjie Xiong, Linlin Sun

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Correction: Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patients

    Correction: Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patients by Tzu-Chun Cheng, Mien-Chie Hung, Lu-Hai Wang, Shih-Hsin Tu, Chih-Hsiung Wu, Yun Yen, Chi-Long Chen, Jacqueline Whang-Peng, Wen-Jui Lee, You-Cheng Liao, Yu-Ching Lee, Min-Hsiung Pan, Hui-Kuan Lin, Huey-En Tzeng, Peixuan Guo, Cheng-Ying Chu, Li-Ching Chen, Yuan-Soon Ho

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patients

    Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patients by Tzu-Chun Cheng, Mien-Chie Hung, Lu-Hai Wang, Shih-Hsin Tu, Chih-Hsiung Wu, Yun Yen, Chi-Long Chen, Jacqueline Whang-Peng, Wen-Jui Lee, You-Cheng Liao, Yu-Ching Lee, Min-Hsiung Pan, Hui-Kuan Lin, Huey-En Tzeng, Peixuan Guo, Cheng-Ying Chu, Li-Ching Chen, Yuan-Soon Ho

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    RNase1-driven ALK-activation is an oncogenic driver and therapeutic target in non-small cell lung cancer

    RNase1-driven ALK-activation is an oncogenic driver and therapeutic target in non-small cell lung cancer by Zhengyu Zha, Chunxiao Liu, Meisi Yan, Cong Chen, Cheng Yu, Yaohui Chen, Chenhao Zhou, Lu Li, Yi-Chuan Li, Hiro Yamaguchi, Leiguang Ye, Tong Liu, Ying-Nai Wang, Heng-Huan Lee, Wen-Hao Yang, Li-Chuan Chan, Baozhen Ke, Jennifer L. Hsu, Lieming Ding, Dong Ji, Peng Pan, Yiran Meng, Yue Pu, Lunxu Liu, Mien-Chie Hung

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: